Moore Capital Management, LP Sarepta Therapeutics, Inc. Transaction History

Moore Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $2.09 Million - $2.52 Million	20,400 New	20,400 $2.47 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $11.6 Million - $15.4 Million	98,789 Added 547.91%	116,819 $16.1 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $16.3 Million - $21.4 Million	-162,030 Reduced 89.99%	18,030 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $7.55 Million - $11.9 Million	99,760 Added 124.23%	180,060 $19.9 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $3.24 Million - $4.57 Million	51,622 Added 180.01%	80,300 $6.02 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $1.81 Million - $2.59 Million	28,678 New	28,678 $2.24 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $869,627 - $1.18 Million	-7,750 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $512,336 - $728,519	-4,803 Reduced 38.26%	7,750 $924,000
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $735,057 - $1.12 Million	7,553 Added 151.06%	12,553 $1.37 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $461,240 - $646,040	-4,000 Reduced 44.44%	5,000 $808,000
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $645,660 - $1.38 Million	9,000 New	9,000 $1.19 Million

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.